Alnylam, Halozyme among latest firms to win EU backing for drugs

Apr. 28, 2025 12:04 PM ETHalozyme Therapeutics, Inc. (HALO) Stock, ALNY StockBy: Nilanjana Basu, SA News Editor
(1min)
EUROPEAN UNION Flag Button - 3D Rendering

porcorex/iStock via Getty Images

Alnylam Pharmaceuticals (NASDAQ:ALNY) and Halozyme Therapeutics (NASDAQ:HALO) announced Monday that an advisory panel of the European Medicines Agency (EMA) endorsed their drugs for marketing authorization.

Alnylam said that the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ALNY
--
HALO
--